3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract manufacturing agreement
[Noáin, Spain, October 26, 2020]3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement withSpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases.
More info >> |